Publication | Closed Access

A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck

MedicineMetronomic TherapyPhase Ii StudyHead And Neck CancerHead And Neck SurgeryMetronomic ChemotherapyCancer TreatmentNeck OncologyRadiation OncologyOncologyCancer ChemotherapySingle Agent CisplatinCancer ResearchRadiologyHealth Sciences